U.S. Assisted Reproductive Technology Market Size & Outlook
U.S. assisted reproductive technology market, 2018-2030 (US$M)
Related Markets
U.S. assisted reproductive technology market highlights
- The U.S. assisted reproductive technology market generated a revenue of USD 5,761.5 million in 2023 and is expected to reach USD 8,079.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, in vitro fertilization (ivf) was the largest revenue generating type in 2023.
- Artificial Insemination is the most lucrative type segment registering the fastest growth during the forecast period.
Assisted reproductive technology market data book summary
| Market revenue in 2023 | USD 5,761.5 million |
| Market revenue in 2030 | USD 8,079.5 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | In vitro fertilization (ivf) |
| Fastest growing segment | Artificial Insemination |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In Vitro Fertilization (IVF), Artificial Insemination |
| Key market players worldwide | Micromem Technologies Inc, CooperSurgical, FUJIFILM Holdings Corp, Vitrolife AB ADR, European Sperm Bank, Merck KGaA, Ferring, Bloom IVF |
Other key industry trends
- In terms of revenue, U.S. accounted for 20.9% of the global assisted reproductive technology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. assisted reproductive technology market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,079.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Assisted Reproductive Technology Market Scope
Assisted Reproductive Technology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. assisted reproductive technology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to assisted reproductive technology market will help companies and investors design strategic landscapes.
In vitro fertilization (ivf) was the largest segment with a revenue share of 91.66% in 2023. Horizon Databook has segmented the U.S. assisted reproductive technology market based on in vitro fertilization (ivf), artificial insemination covering the revenue growth of each sub-segment from 2018 to 2030.
According to a report published by the Society for Assisted Reproductive Technology, the number of ART treatments has increased in the U.S. These treatments not only boosted the number of live births but also reduced the rate of multiple births.
In March 2022, the Government of Newfoundland and Labrador created an IVF Subsidy Program to address the difficulties some citizens face in accessing IVF services.
This program provides USD 5,000 for each IVF cycle for applicants that meet clinical eligibility and up to three IVF cycles throughout their lifetime. Thus, such government initiatives are boosting market growth.
Reasons to subscribe to U.S. assisted reproductive technology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. assisted reproductive technology market databook
-
Our clientele includes a mix of assisted reproductive technology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. assisted reproductive technology market , including forecasts for subscribers. This country databook contains high-level insights into U.S. assisted reproductive technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. assisted reproductive technology market size, by type, 2018-2030 (US$M)
U.S. Assisted Reproductive Technology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
